The economics of upper gastrointestinal bleeding in a US managed-care setting: A retrospective, claims-based analysis

Journal of Medical Economics

Volumn 13, Issue 1, 2010, Pages 70-77

  Cryer, B L ^a   Wilcox, C M ^b   Henk, H J ^c   Zlateva, G ^d   Chen, L ^d   Zarotsky, V ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c i3 Innovus   (United States)

^d PFIZER INC   (United States)

Author keywords

Claims analysis; Costs; Economics; Gastrointestinal disease; Hemorrhage

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; UPPER GASTROINTESTINAL BLEEDING;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COSTS; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; UPPER GASTROINTESTINAL TRACT; YOUNG ADULT;

EID: 77149161157     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990903526676     Document Type: Article

References (22)

1. Boonpongmanee S, Fleischer DE, Pezzullo JC, et al. The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc 2004;59:788-794.
2. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-727.
3. Wilcox CM, Clark WS. Causes and outcome of upper and lower gastrointestinal bleeding: the Grady Hospital experience. South Med J 1999;92:44-50.
4. Yavorski RT, Wong RK, Maydonovitch C, et al. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995;90:568-573.
5. Vreeburg EM, Snel P, de Bruijne JW, et al. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997;92:236-243.
6. Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population based study. Am J Gastroenterol 1997;92:419-424.
7. Manning-Dimmitt LL, Dimmitt SG, Wilson GR. Diagnosis of gastrointestinal bleeding in adults. Am Fam Physician 2005;71: 1529-1537.
8. American Society for Gastrointestinal Endoscopy. AGSE guideline: the role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004;60:497-504.
9. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-321
10. Lee JG. The role of endoscopy in triage of patients with upper-GI bleeding. Clin Update 2005;12:1-4.
11. Goldfarb NI, Phillips A, Conn M, et al. Economic and health outcomes of capsule endoscopy: opportunities for improved management of the diagnostic process for obscure gastrointestinal bleeding. Disease Manage 2002;5:123-135.
12. Solomon DH, Glynn RJ, Bohn RLR, et al. The hidden cost of nonselective nonsteroidal anti-inflammatory drugs in older patients. J Rheumatol 2003;30:792-798.
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
14. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
15. Leontiadis GI, Sreedharan A, Dorward S, et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007;11:1-164.
16. Chan FK, Hung LC, Suen BY, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002;347:2104-2110.
17. Lai KC, Chu KM, Hui WM, et al. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Am J Med 2005;118:127-128.
18. lensen DM, Cheng S, Kovacs TO, et al. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994;330:382-386.
19. Wolde S, Dijkmans BA, Janssen M, et al. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. Aliment Pharmacol Ther 1996;10:347-351.
20. Massó González EL, García Rodríguez LA. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. Aliment Pharmacol Ther 2008;28:629-637.
21. Rahme E, Barkun AN, Toubouti Y, et al. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? Arthritis Rheum 2007;57:748-755.
22. Enns RA, Gagnon YM, Rioux KP, et al. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2003;17:225-233.